Synthesis, cytotoxicity and liver targeting of 3-O-β-D-Galactosylated Resveratrol.

Jiajia QianLiqiong ZhaBeilei WangCaiyun ZhangLufeng HongWeidong Chen

Published in: The Journal of pharmacy and pharmacology (2019)

On the whole, Gal-Res increased cellular uptake to HepG2 cells, bioavailability and liver targeting, providing its future clinical application in the treatment of liver diseases.

Keyphrases

cancer therapy
current status
drug delivery